Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;65(5):373-380.
doi: 10.1007/s00106-016-0227-6.

[Imaging-based diagnosis of vestibular schwannoma]

[Article in German]
Affiliations
Review

[Imaging-based diagnosis of vestibular schwannoma]

[Article in German]
C Strasilla et al. HNO. 2017 May.

Abstract

Magnetic resonance imaging (MRI) is the imaging method of choice for patients with vestibular schwannoma, with almost 100 % sensitivity and specificity. The role of computed tomography (CT) is limited to preoperative planning and the postoperative phase. High-resolution sequences and the application of gadolinium-based i.v. contrast medium are crucial for MRI-based diagnosis. Description of the size and location of the tumor, as well as its relationship to adjacent structures and anatomic features, is essential, since these factors, in addition to clinical findings, influence the type of treatment, surgical options, and associated risks. A postoperative linear contrast enhancement is often seen for up to 6 months and sometimes even longer. However, if this is of nodular structure, a recurrent schwannoma is likely. A sufficient statement regarding tumor response is not possible within the first 24 months after stereotactic radiosurgery. An increasing tumor volume after 24 months indicates failure of the treatment. Knowledge of the features of vestibular schwannomas allows all other possible differential diagnoses to be confidently excluded.

Keywords: Acoustic neuroma; Computed tomography, X‑ray; Contrast media; Magnetic resonance imaging; Neurofibromatosis 2.

PubMed Disclaimer

References

    1. AJNR Am J Neuroradiol. 2008 May;29(5):906-10 - PubMed
    1. Laryngoscope. 2012 Feb;122(2):378-88 - PubMed
    1. AJNR Am J Neuroradiol. 2007 Oct;28(9):1633-8 - PubMed
    1. Hong Kong Med J. 2004 Feb;10(1):38-43 - PubMed
    1. Expert Rev Neurother. 2009 Aug;9(8):1219-32 - PubMed